Isomorphic Labs · 201–500 people · Series A
Research Leader (In-vitro Pharmacology, Exploratory Sciences)
- London
- Hybrid · 3 days in office
- Lead · manages people
Lead a team of biologists in the Exploratory Sciences group, owning in vitro pharmacology strategy for novel modalities such as TPD, molecular glues and peptides. Design screening cascades and quantitative assays, manage CRO studies, and champion LLM agentic workflows and in silico hypothesis building alongside ML and engineering colleagues.
SPR · GCI · nanoDSF +5